Canada House Wellness Group Announces Fulfillment of First Purchase Orders to SQDC

IsoCanMed Inc. begins processing weekly purchase orders in accordance with existing Letter of Intent with SQDC TORONTO, Oct. 7, 2020 /CNW/ – Canada House Wellness Group (CSE: CHV) (“Canada House” or the “Company“), a fully integrated medical cannabis company, is pleased to announce that its wholly owned subsidiary, IsoCanMed Inc. (“ICM“), has fulfilled its first purchase orders under the termsContinue reading “Canada House Wellness Group Announces Fulfillment of First Purchase Orders to SQDC”

Emerald Health Therapeutics and Quinto Resources Enter into Share Purchase Agreement for Sale of Quebec Cannabis Business

– July 31, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH)  (“Emerald”) and Quinto Resources Inc. (“Quinto”) (TSXV: QIT) today announced that they have entered into a share purchase agreement dated July 30, 2020 (the “Agreement”) in respect of the sale of Emerald’s wholly-owned subsidiaries, Verdélite Sciences, Inc. (“Verdélite Sciences”) and Verdélite Property Holdings, Inc.Continue reading “Emerald Health Therapeutics and Quinto Resources Enter into Share Purchase Agreement for Sale of Quebec Cannabis Business”

Canada House Wellness Group Announces $6.5 Million Strategic Investment From Archerwill Investments

-Canada House Wellness Group Inc. (CSE: CHV) (“Canada House“, or the “Company“), is pleased to announce that it has entered into a subscription agreement (the “Subscription Agreement“) with Archerwill Investments Inc. (“Archerwill“) for a strategic investment in Canada House (the “Transaction“). Transaction Highlights Archerwill will invest $6,500,000 in the form of a secured convertible debenture (the “Debenture“) to obtain aContinue reading “Canada House Wellness Group Announces $6.5 Million Strategic Investment From Archerwill Investments”

HEXO Corp. Announces Final Closing of Early Conversion Option for Debentures

— HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced the final closing of its previously announced early conversion option (the “Early Conversion Option”) in respect of $29.86 million aggregate principal amount of its outstanding $70 million aggregate principal amount of 8% unsecured convertible debentures maturing December 5, 2022 (the “Debentures”). UnderContinue reading “HEXO Corp. Announces Final Closing of Early Conversion Option for Debentures”

Relevium Expands CleanCare Offering as International Organizations Call for Increased Institutional and Government Stockpile of Supplies

— Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has expanded and continues to expand its CleanCare™ product line as it prepares to address increased government and institutional demand for disinfection supplies in preparation for a potential second wave of COVID-19. On June 18,Continue reading “Relevium Expands CleanCare Offering as International Organizations Call for Increased Institutional and Government Stockpile of Supplies”

HEXO Corp. Announces C$34,500,000 At-the-Market Offering Program

— HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that it has established an at-the-market equity program (the “ATM Program”) that allows the Company to issue up to C$34,500,000 (or its U.S. dollar equivalent) of common shares (the “Common Shares”) from treasury to the public from time to time, at theContinue reading “HEXO Corp. Announces C$34,500,000 At-the-Market Offering Program”

HEXO Corp. reports third quarter fiscal 2020 financial results; Net Revenue Up 30% to $22.1 Million, Improved Operational Performance

Key Operating Highlights Gross Revenue increased 30% to $30.9M from $23.8M in Q2 Net Revenue increased 30% to $22.1M from $17.0M in Q2 Adult-use grams and gram equivalents sold increased 42% to 9,338 kg compared to Q2 Gross Margins increased to 40% Operating expenses decreased to $26.8M Closed $46M public offering to enhance liquidity AdjustedContinue reading “HEXO Corp. reports third quarter fiscal 2020 financial results; Net Revenue Up 30% to $22.1 Million, Improved Operational Performance”

HEXO launches new Tsunami 30 g flower format exclusively to medical clients

OTTAWA, June 03, 2020 (GLOBE NEWSWIRE) — HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is proud to launch new 30 gram medical flower format for its popular high-THC strain Tsunami under HEXO medical cannabis. HEXO has been dedicated to providing Canadian clients high quality medical cannabis since 2015. A year ago, theContinue reading “HEXO launches new Tsunami 30 g flower format exclusively to medical clients”

Neptune Announces Launch of Neptune Air Non-Contact Thermometer

Neptune to rapidly increase North American supply of safe and effective non-contact thermometers in response to COVID-19 LAVAL, QC, May 12, 2020 /PRNewswire/ – Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT), a leader in natural health and wellness products, is pleased to announce today the launch of Neptune Air, a non-contact infrared thermometer (NCIT) optimizedContinue reading “Neptune Announces Launch of Neptune Air Non-Contact Thermometer”